Have you read these stories?

Rakesh Jhunjhunwala being probed for insider trading

Sebi issues summons to investor Jhunjhunwala, some family members and Aptech directors.
The Economic Times

SEARCHED FOR:

NILESH MAZUMDAR

Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-Shaw

It looks to build a pipeline of 28 biosimilars across global markets in three phases.

ET Prime Distribution
Load More...
x

Other useful Links


Copyright © 2020 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service